Once-monthly efimosfermin alfa in participants with metabolic dysfunction-associated steatohepatitis with F2/F3 fibrosis: post hoc results from a 24-week, randomized, double-blind, placebo-controlled, phase 2 trial
作者
Jörn Markus Schattenberg,Rohit Seth Loomba,Kris V. Kowdley,Muhammad Y. Sheikh,N J Kim,Anita Kohli,E J Lawitz,B Jeglinksi,Kelly Kutch,J M Trigo,Patricia Mendez,Margaret James Koziel,Stuart Kendrick,S Mukherjee,Mazen Noureddin
出处
期刊:Zeitschrift Fur Gastroenterologie [Thieme Medical Publishers (Germany)] 日期:2026-08-01卷期号:64 (08): e255-e256